ASA Biopharm's Podcast
In this podcast series sponsored by Biopharmaceutical Section of American Statistical Association, key opinion leaders from pharmaceutical industry and regulatory agencies talk about upcoming statistical conferences and events, and discuss current issues in Biopharmaceutical statistics.
Episodes
111 episodes
Episode 110: STATBOLIC Cardiometabolic Statistical Workshop
Jürgen Hummel, Hiya Banerjee, Jingyi Liu, Jason Legg, and Henrik Ravn discuss the inaugural STATBOLIC Workshop.
•
27:39
Episode 109: Ian Sturdy
Ian describes how to leverage ChatGPT to accelerate statistical programming in the medical product industry.Related paper available here: https://www.pharmasug.org/proceedings/2024/AP/PharmaSUG-2024-AP-256.pdf
•
33:32
Episode 108: Working Moms
Elaine Hoffman, Rebbecca Wilson, Christina Nurse, and Amy LaLonde discuss the balancing act between family and career.
•
37:09
Episode 107: SPAIG Committee
Scott Clark, Satrajit Roychoudhury, and Michelle Shardell discuss the Statistical Partnerships Among Academe, Industry & Government (SPAIG) Committee.https://community.amstat.org/spaig/home
•
27:32
Episode 106: Rebbecca Wilson
Amy welcomes Rebbecca to the co-hosting chair while Christina enjoys some time off with her new baby (congrats)! The two discuss Rebbecca’s fascinating career thus far and how communication styles differ across male and female leaders.Re...
•
40:00
Episode 105: Adrian Coles and Wendy Martinez
Adrian and Wendy discuss imposter syndrome and being confident in your career.
•
43:59
Episode 104: Steve Ruberg
In our first episode of the new year, we interview Steve Ruberg, an ASA fellow with over 35 years of experience in the biopharmaceutical industry and an active proponent of the Tripartite Estimand Approach.
•
1:01:33
Episode 103: Tian Gu
Tian discusses her research in data integration methods and the bias arising from lack of representation.
•
28:15
Episode 102: LaShell Robinson
LaShell discusses diversity, equity, and inclusion in clinical trials.
•
36:45
Episode 101: Elizabeth Mannshardt-Hawk on Imposter Syndrome
Elizabeth discusses imposter syndrome and how to manage it in your statistical career. In collaboration with the ASA's Committee on Career Development (CCD website) .
•
45:48
Episode 100: Dionne Price, ASA President-Elect
Dionne talks about her journey in biostatistics and her goals for the ASA when she becomes President in 2023.
•
37:10
Episode 99: Amy LaLonde and Christina Nurse
This episode introduces new podcast cohosts Amy LaLonde and Christina Nurse! They take over hosting duties starting with Episode 101.
•
33:46
Episode 98: Safety Scientific Working Group
James Buchanan, Judy Li, Melvin Munsaka, and Bill Wang discuss the research of the Safety Scientific Working Group and their recent edited volume "Quantitative Drug Safety and Benefit Risk Evaluation: Practical and Cross-Disciplinary Approaches...
•
53:45
Episode 97 - Devan Mehrotra
Devan discusses the 5-STAR methodology and endpoints for COVID vaccine clinical trials.
•
49:11
Episode 96: Alan Hartford
Alan is the 2022 Chair of the Biopharmaceutical Section. He discusses his wish list for things to accomplish this year.
•
32:12
Episode 95: Anna Nevius
Anna Nevius reflects on her time at the Center for Veterinary Medicine at the FDA and as chair of the Biopharmaceutical Section in 2009.
•
31:16
Episode 94: Bob Starbuck
Bob Starbuck reflects on his time as chair of the Biopharmaceutical Section in 1994.
•
34:29
Episode 93: External Control Arms
Amy Xia and Lanju Zhang discuss the benefits and challenges of utilizing external control arms for clinical trials.
•
53:53
Episode 92: 2021 Regulatory-Industry Statistics Workshop
Bo Huang and Gene Pennello discuss the 2021 Regulatory-Industry Statistics Workshop.
•
35:51
Episode 91: Patient Reported Outcomes
Joseph Cappelleri and Daniel O’Connor discuss the benefits and challenges in using patient reported outcomes and how to appropriately define clinically-meaningful change.
•
1:02:04
Episode 90: ICSA Leadership Panel
Haoda Fu, Mengling Liu, Jie Tang, Tian Zheng, and Kelly Zou discuss leadership and the impact of COVID-19 on the workplace.
•
31:38
Episode 89: Karl Peace
Karl Peace was chair of the Biopharmaceutical Section in 1990. He discusses his career in the industry, the Jiann-Ping Hsu College of Public Health, and the Biopharmaceutical Applied Statistics Symposium.
•
47:43